ABSTRACT. The hypothesis has been proposed that cell proliferation, or replicative DNA synthesis (RDS) in S-phase cells, is a nongenotoxic (Ames-negative) mechanism involved in tumorigenesis, providing a very useful conceptual basis for carcinogen testing. In this present study, hepatocyte RDS experiments were conducted using 5-bromo-2'-deoxyuridine (BrdU) labeling in combination with histopathological observation, comparing our results with earlier findings for in situ [ 3 H]thymidine (TdR) labeling. The present BrdU data proved to be consistent with the previous TdR data in all but one case. Hepatocyte RDS induction was observed for some chemicals without hepatotoxicity. BrdU labeling in combination with histopathological observation is therefore a reliable approach to assessment of test compound effects in vivo. The livers were fixed in 10% neutral phosphate-buffered formalin for 24 hr and embedded in paraffin. Two serial sections of each specimen were cut at 5-µm thickness; one was stained immunohistochemically with anti-BrdU monoclonal antibodies, and the other with hematoxylin and eosin (HE). All procedures described below were performed at room temperature. For immunostaining, sections were deparaffinized in xylene, passed through graded alcohols and then treated with 2N-HCl for 30 min to denature doublestranded DNA. After being rinsed twice for 5 min each in cold boric borate buffer (pH 7.6), the sections were digested with 0.05% pronase E (Serva Feinbiochemica GmbH & Co., Heidelberg, Germany) in phosphate-buffered saline (pH 7.4) for 5 min. Endogenous peroxidase was inhibited by exposure to 3% hydrogen peroxide for 5 min. After treatment with bovine serum albumin to eliminate nonspecific binding, the sections were incubated for 20 min with anti-BrdU antibodies diluted 1:40 in 0.05 M Tris-HCl buffer (pH 7.6). After this primary antibody exposure, the slides were incubated for 10 min with biotinylated goat antimouse Ig/rabbit Ig and then for 10 min with peroxidase conjugated streptavidin. BrdU incorporation was detected by a final incubation with 3,3'-diaminobenzidine Chemically-induced in vivo cell division, or replicative DNA synthesis (RDS) in the S-phase, provides us with an attractive parameter for investigating the mechanisms of carcinogenesis in rodents and man. The available data indicate that in some cases cell proliferation may play a more important role in the induction of preneoplastic lesions than genotoxicity [3, 5, 6, 15, 28] . Considerable interest concerning RDS induction has been focused on the involvement of genetic instability [20] , and examination of the link with chemically induced tumor development has substantially improved our understanding of the mechanisms of hepatocarcinogenesis. Experiments to determine hepatocyte RDS induction have mostly been conducted using in situ [ 3 H]thymidine (TdR) labeling [2, 7, 15, 17-19, 26, 27], but in some cases 5-bromo-2'-deoxyuridine (BrdU) incorporation [6, 9] or both techniques [8, 14] were applied. Data on hepatocyte turnover have thus accumulated for each individual technique, but an assessment of the validity of BrdU labeling for testing purposes after hepatocarcinogen application has hitherto been lacking. Using our extensive data base [26] , generated with the in situ TdR-technique, we therefore ascertained whether BrdU labeling is as sensitive for detection of hepatocarcinogens under the same experimental conditions, providing a firm rationale for application of BrdU incorporation in testing procedures.
ad libitum and were acclimated for one week prior to commencement of the experiments. The maximum tolerated dose (MTD) was applied for each nongenotoxic hepatocarcinogen, the values being obtained by simple acute toxicity testing [26] . Based on the optimum peak RDS induction demonstrated by the TdR technique [26] , treatment intervals (24, 39 or 48 hr) were selected with dose levels of MTD or 1/2 MTD and the test chemicals were re-examined with the BrdU-labeling approach. Control animals were untreated. Following treatment with or without each nongenotoxic hepatocarcinogen, all animals were given 100 mg/kg of BrdU (Sigma Chemical Co., MO, U.S.A.) by i.p. injection 2 hr before sacrifice, when their livers were removed and processed for assessment of BrdU labeling of hepatocytes and histopathological changes.
The livers were fixed in 10% neutral phosphate-buffered formalin for 24 hr and embedded in paraffin. Two serial sections of each specimen were cut at 5-µm thickness; one was stained immunohistochemically with anti-BrdU monoclonal antibodies, and the other with hematoxylin and eosin (HE). All procedures described below were performed at room temperature. For immunostaining, sections were deparaffinized in xylene, passed through graded alcohols and then treated with 2N-HCl for 30 min to denature doublestranded DNA. After being rinsed twice for 5 min each in cold boric borate buffer (pH 7.6), the sections were digested with 0.05% pronase E (Serva Feinbiochemica GmbH & Co., Heidelberg, Germany) in phosphate-buffered saline (pH 7.4) for 5 min. Endogenous peroxidase was inhibited by exposure to 3% hydrogen peroxide for 5 min. After treatment with bovine serum albumin to eliminate nonspecific binding, the sections were incubated for 20 min with anti-BrdU antibodies diluted 1:40 in 0.05 M Tris-HCl buffer (pH 7.6). After this primary antibody exposure, the slides were incubated for 10 min with biotinylated goat antimouse Ig/rabbit Ig and then for 10 min with peroxidase conjugated streptavidin. BrdU incorporation was detected by a final incubation with 3,3'-diaminobenzidine Chemically-induced in vivo cell division, or replicative DNA synthesis (RDS) in the S-phase, provides us with an attractive parameter for investigating the mechanisms of carcinogenesis in rodents and man. The available data indicate that in some cases cell proliferation may play a more important role in the induction of preneoplastic lesions than genotoxicity [3, 5, 6, 15, 28] . Considerable interest concerning RDS induction has been focused on the involvement of genetic instability [20] , and examination of the link with chemically induced tumor development has substantially improved our understanding of the mechanisms of hepatocarcinogenesis. Experiments to determine hepatocyte RDS induction have mostly been conducted using in situ [ 3 H]thymidine (TdR) labeling [2, 7, 15, 17-19, 26, 27] , but in some cases 5-bromo-2'-deoxyuridine (BrdU) incorporation [6, 9] or both techniques [8, 14] were applied. Data on hepatocyte turnover have thus accumulated for each individual technique, but an assessment of the validity of BrdU labeling for testing purposes after hepatocarcinogen application has hitherto been lacking. Using our extensive data base [26] , generated with the in situ TdR-technique, we therefore ascertained whether BrdU labeling is as sensitive for detection of hepatocarcinogens under the same experimental conditions, providing a firm rationale for application of BrdU incorporation in testing procedures.
A total of 22 nongenotoxic hepatocarcinogens were examined in this present study. The sources of these chemicals were described in our previous report [26] . For administration to animals, methyl carbamate, phenobarbital sodium (PB), tannic acid and urethane were dissolved in distilled water, and the remaining 18 chemicals were dissolved or suspended in corn oil (Junsei Chemical Co., Tokyo, Japan).
Male F344 rats were obtained from Charles River Japan Inc. (Kanagawa, Japan) at 8 weeks of age and housed in polycarbonate cages with 3 or 4 animals per cage under controlled room conditions. Animals received rodent MF chow of Oriental Yeast Co. (Tokyo, Japan) and tap water tetrahydrochloride in 0.05 M Tris-HCl buffer, followed by the addition of 0.03% hydrogen peroxide. The slides were rinsed twice with 0.05 M Tris-HCl buffer between all steps. Finally, the sections were also lightly counterstained with hematoxylin. All immunohistochemical reagents used for detecting BrdU-labeled cells were purchased from DAKO Co. (CA, U.S.A.). The BrdU procedure used was essentially performed according to the published methods of other investigators [11] , with minor modifications. Staining of serial sections was also done with HE for each liver specimen to allow observation of any histopathological alterations with concentration of attention on those associated with cell turnover.
RDS incidences were calculated as percentages of BrdUincorporating cells relative to 1,000 hepatocytes counted per animal. Statistical analyses were performed with the Student's t-test.
In the present experiment, the spontaneous BrdU-labeling incidence was determined to be 1.2% ± 0.5 (mean ± SE, n=59 rats). The threshold for a positive result was therefore set at an incidence of 2.7%, calculated as the mean + 3 × SE. RDS results obtained with the BrdU techniques are shown in Table 1 . With the judgment criterion of 2.7% for BrdU, 4 of the 22 hepatocarcinogens, 11-aminoundecanoic acid, chlorendic acid, D,L-ethionine and urethane, did not give positive results. In 3 of these cases, negative data were also obtained with TdR detection (Table 1 ). The one chemical showing a discrepancy was urethane. With the BrdU incorporation, the remaining 18 positive samples gave clear increases in RDS incidence with values ranging from 2.9 to 35.0%. The same chemicals were also positive with TdR detection, although the RDS values did not directly correspond between the 2 cases. For example, the RDS values for p,p'-dichlorodiphenyltrichloroethane (p,p'-DDT), di(2-ethylhexyl)phthalate (DEHP), 1,4-dioxane, methyl carbamate, polybrominated biphenyls (PBB), tannic acid and thioacetamide were far higher than those with TdR detection. In contrast, the RDS values for acetaminophen and carbon tetrachloride were approximately 1/2 of the TdR.
Histopathological changes were also observed in some cases (Table 1) . On this basis the nongenotoxic hepatocarcinogens were classified into group I (histopathological changes observed) and group II (no histopathological changes observed). Group I comprised 11 chemicals which induced cell turnover in hepatocytes. The features observed were principally associated with toxicity and cell turnover. They included hepatocellular vacuolation and necrosis, especially in the centrilobular zone, prominent nucleoli, increased numbers of mitotic figures and increased quantity of nuclear chromatin. Reactive cell infiltration was also occasionally noted. However, the correlation between the level of RDS induction and the degree of histopathological lesions was not absolute. Group II with no histopathological changes was also composed of 11 chemicals, as shown in Table 1 . Four of these, 11-aminoundecanoic acid, chlorendic acid, D,Lethionine and urethane, did not give positive RDS data in terms of BrdU incorporation.
Representative photographs illustrating histopathological changes (HE staining) and BrdU staining are showed in Figs. 1-6 . The two chemicals, clofibrate and Wy-14,643, are both known to be peroxisome-proliferators which are hepatocarcinogenic in the rat [16] . Untreated controls (Fig.  1) and clofibrate-treated rat livers (Fig. 2) exhibited no histopathological changes reflective of any hepatotoxicity. Wy-14,643-treated rat livers showed an increase in nuclear chromatin (Fig. 3) . Both clofibrate-treated (Fig. 5) and Wy-14,643-treated (Fig. 6 ) rat livers demonstrated increased hepatocyte division as reflected by enhanced BrdU incorporation, with similar RDS incidences of 3-to 4-fold the control values (Fig. 4) .
The aim of the present study was to evaluate whether BrdU incorporation, which is a marker of cell proliferation, is as sensitive as TdR labeling. Comparison revealed consistent findings with the 2 methods, with the exception of the urethane case, for a positive or negative status, according to our defined judgment criteria ( Table 1 ). The present BrdU-labeling data allowed simple grouping into negatives and positives: moreover, positives could be further classified into 2 categories, those with and without histopathological lesions, although it is necessary to stress that the latter case, without lesions is dependent to some extent on dosage and treatment time. The fact that some nongenotoxic hepatocarcinogens showed negative RDS responses with both the BrdU and TdR techniques might be related to the single exposure applied (Table 1) . Compared to 2-year animal bioassays, short-term administration is likely to differ with regard to biotransformation of highly toxic intermediates and drug distribution. Thus, our RDS approach suffers from a weakness, but this applies equally to other short-term methods for detecting effects of test chemicals. Furthermore, it should be stressed that the majority of nongenotoxic hepatocarcinogens used revealed positive responses with (group I) or without (group II) histopathological changes.
Chemically induced hepatocyte necrosis is well known to lead to regenerative hepatocyte turnover. It may be due to disruption of ionic pumps at the plasma membrane associated with cytoskeletal disorders, cellular and organelle swelling, cell shape changes and blebbing of the cell membrane. Centrilobular vacuolation of hepatocytes, necrosis and reactive cell infiltration were selected as typical signs of toxicity. Other markers, such as prominent nucleoli, increased quantity of nuclear chromatin and increased numbers of mitotic figures, are occasionally found as evidence of hepatocyte division in the absence of hepatotoxicity. With respect to the 11 nongenotoxic hepatocarcinogens which demonstrated an ability to cause histopathological changes, clearly increased RDS incidences were apparent (Table 1 ). The underlying mechanism might involve paracrine effects through HGF production and release by non-parenchymal cells in the liver [12, 13] , with the HGF-binding receptor being identified as the met protooncogene product [1] . Chemicals possessing hepatotoxicity a) RDS incidences are the percentages of RDS positive hepatocytes calculated from data for 1000 hepatocytes/liver ± SE. Based on our final judgment criteria, incidences of 2.7% or more were judged as positive responses, those less than 2.7% being negative. Asterisks (*) indicate a significant increase compared to the relevant controls (* P<0.01). b) RDS values were obtained by the TdR-incorporation technique in our previous study [26] , so that the data are parenthesized. RDS incidences are the percentages of RDS positive hepatocytes calculated from data for 2000 hepatocytes/liver ± SE. RDS incidences of 1% or more were judged as positive responses, those less than 1% being negative [25] . c) Control level is the mean ± SE obtained from 10 experiments using 59 rats. d) The data were from our previous study [24] , based on 105 experiments using 422 rats. might also stimulate proliferation directly. As far as our observations on BrdU labeling and histopathological data are concerned (Table 1) , it can not be stated that there is a direct relationship between hepatotoxicity and hepatocyte division. This clearly has a bearing on the unsolved problem of whether only toxicity leading to hepatocyte turnover is important for carcinogenicity.
With the hepatocarcinogens classified as causing no visible toxicity, hepatocyte RDS induction is usually associated with steroid-thyroid-retinoic acid receptor-mediated activation [4, 5, 10, [21] [22] [23] . Candidates are the estrogen receptor for 17α-ethynylestradiol; the aromatic hydrocarbon receptor for p,p'-DDT and PBB; and the peroxisome proliferator-activated receptor for clofibrate, DEHP, PB and Wy-14,643. Thus, hepatocyte proliferation caused by hepatocarcinogens might be due to HGF paracrine-mediated and/or steroid-thyroid-retinoic acid receptor-mediated processes. With no histopathological changes, receptor-mediated cell division may be most important, in line with the genetic instability theory [20] . The present findings (Table 1) demonstrate that BrdU incorporation coupled with histopathological observation is at least as sensitive as in situ TdR techniques for analyzing cell turnover. Almost all carcinogens are believed to cause cell turnover as well as having genotoxic potential in target tissues and organs: therefore, we have focused our efforts on the best available method for observation of cell proliferation. The BrdU approach coupled with histopathological observations has many advantages for this purpose. Further studies with the present assay system are now ongoing to ascertain what factors are of relevance to the induction of RDS by the chemicals tested in the present experiment. Fig. 1 . Light micrograph of a liver section from an untreated rat. HE staining, × 180. Fig. 2 . Light micrograph of a liver section from a rat treated with clofibrate. No histopathological changes are evident. HE staining, × 180. Fig. 3 . Light micrograph of a liver section from a rat treated with Wy-14,643. An increase in nuclear chromatin (arrows) is apparent. HE staining, × 180. Fig. 4 . Light micrograph of a liver section from an untreated rat. BrdU immunostaining, × 90. Fig. 5 . Light micrograph of a liver section from a rat treated with clofibrate. An increase in the number of RDS positive cells is apparent.
BrdU immunostaining, × 90. Fig. 6 . Light micrograph of a liver section from a rat treated with Wy-14,643. An increase in the number of RDS positive cells is apparent.
BrdU immunostaining, × 90.
